Foreign technology start-ups like Inteliclinic Inc and Embr Labs Inc are taking part in the Computex Taipei this year, looking for manufacturing partners and investors in Taiwan.
San Francisco-based Inteliclinic, with its wearable mask capable of analyzing and improving sleep quality, is seeking Taiwanese contract electronics and textile manufacturers as part of the firm’s plans to expand its reach to East Asian markets.
“We would like here [Taiwan] to be our window to Asia, given that Japan is one of our largest markets,” Inteliclinic cofounder and general manager Tomasz Kolodziejak told the Taipei Times at the company’s booth at the annual trade show.
Since raising US$500,000 from crowdfunding platform Kickstarter in 2014, Inteliclinic has grown into a small company with 20 employees over the past two years.
Its smart intelligent sleep mask, called Neuroon, measures the body’s brain waves, pulse, temperature and physical motion. The data is then analyzed using an application developed by the company to recommend the best Neuroon features and therapies to help one sleep better, according to information posted on the company’s Web site.
Users can also access their sleep data, such as the length of time it takes them to fall asleep or their rapid eye movement sleep, business development manager Ryan Goh said.
Working in cooperation with a Polish manufacturer, Inteliclinic has sold nearly 7,000 units, mainly in the US and Japan, via its Web site and Amazon.com over the past two years, Goh said.
Inteliclinic plans to extend its business to South Korea, Hong Kong, Singapore and Taiwan via a manufacturing hub here, Goh said.
The start-up has talked to three to four potential manufacturing partners, including large Taiwanese textile suppliers, and has inked a letter of intent with six international airlines, including Deutsche Lufthansa AG, Virgin Atlantic and All Nippon Airways (ANA), he added.
Starting next month, Inteliclinic will begin supplying Neuroon masks for Lufthansa’s Frankfurt-San Francisco flights, Goh said.
Inteliclinic’s client base mainly consists of retail consumers and airlines, but the company will start supplying a boutique hotel in downtown San Francisco in fall this year, it said.
To support its expansion, Inteliclinic is planning to hold its first round of venture capital fundraising, hoping to attract institutional investors and raise US$4 million this summer, Goh said.
Embr Labs, founded by a research team from the Massachusetts Institute of Technology, said it attended Computex to look for manufacturing and supply chain partners, as well as “a little bit” of investment.
Incorporated in Massachusetts in 2014, the company is developing active wearable technology to reduce thermal stress caused by uncomfortable environments.
“We have a patent-pending technology for wearables to heat and cool people directly, helping them feel more comfortable,” Embr Labs cofounder Samuel Shames said at the company’s booth.
The technology is still in the prototype stage and the company has not decided on what kind of wearable device it will be, he said.
It hopes to make a major announcement later this year and provide more product details, he said.
Shames said the company has talked to several Taiwanese companies over the past few days.
They could be manufacturing partners or even potential investors, he said, without elaborating.
Singapore-based ride-hailing and delivery giant Grab Holdings Ltd has applied for regulatory approval to acquire the Taiwan operations of Germany-based Delivery Hero SE's Foodpanda in a deal valued at about US$600 million. Grab submitted the filing to the Fair Trade Commission on Friday last week, with the transaction subject to regulatory review and approval, the company said in a statement yesterday. Its independent governance structure would help foster a healthy and competitive market in Taiwan if the deal is approved, Grab said. Grab, which is listed on the NASDAQ, said in the filing that US-based Uber Technologies Inc holds about 13 percent of
The domestic unit of the Chinese-owned, Dutch-headquartered chipmaker Nexperia BV will soon be able to produce semiconductors locally within China, according to two company sources. Nexperia is at the center of a global tug-of-war over critical semiconductor technology, with a Dutch court in February ordering a probe into alleged mismanagement at the company. The geopolitical tussle has disrupted supply chains, with some carmakers reportedly forced to cut production due to chip shortages. Local production would allow Nexperia’s domestic arm, Nexperia Semiconductors (China) Ltd (安世半導體中國), to bypass restrictions in place since October on the supply of silicon wafers — etched with tiny components to
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday received government approval to deploy its advanced 3-nanometer (3nm) process at its second fab currently under construction in Japan, the Ministry of Economic Affairs said in a news release. The ministry green-lit the plan for the facility in Kumamoto, which is scheduled to start installing equipment and come online in 2028 with a monthly production capacity of 15,000 12-inch wafers, the ministry said. The Department of Investment Review in June 2024 authorized a US$5.26 billion investment for the facility, slated to manufacture 6- to 12nm chips, significantly less advanced than 3nm process. At a meeting with
Taiwan’s food delivery market could undergo a major shift if Singapore-based Grab Holdings Ltd completes its planned acquisition of Delivery Hero SE’s Foodpanda business in Taiwan, industry experts said. Grab on Monday last week announced it would acquire Foodpanda’s Taiwan operations for US$600 million. The deal is expected to be finalized in the second half of this year, with Grab aiming to complete user migration to its platform by the first half of next year. A duopoly between Uber Eats and Foodpanda dominates Taiwan’s delivery market, a structure that has remained intact since the Fair Trade Commission (FTC) blocked Uber Technologies Inc’s
RSS